Literature DB >> 30385420

Incorporation and effects of mesoporous SiO2-CaO nanospheres loaded with ipriflavone on osteoblast/osteoclast cocultures.

Laura Casarrubios1, Natividad Gómez-Cerezo2, María José Feito1, María Vallet-Regí3, Daniel Arcos4, María Teresa Portolés5.   

Abstract

Mesoporous nanospheres in the system SiO2-CaO (NanoMBGs) with a hollow core surrounded by a radial arrangement of mesopores were characterized, labeled with FITC (FITC-NanoMBGs) and loaded with ipriflavone (NanoMBG-IPs) in order to evaluate their incorporation and their effects on both osteoblasts and osteoclasts simultaneously and maintaining the communication with each other in coculture. The influence of these nanospheres on macrophage polarization towards pro-inflammatory M1 or reparative M2 phenotypes was also evaluated in basal and stimulated conditions through the expression of CD80 (as M1 marker) and CD206 (as M2 marker) by flow cytometry and confocal microscopy. NanoMBGs did not induce the macrophage polarization towards the M1 pro-inflammatory phenotype, favoring the M2 reparative phenotype and increasing the macrophage response capability against stimuli as LPS and IL-4. NanoMBG-IPs induced a significant decrease of osteoclast proliferation and resorption activity after 7 days in coculture with osteoblasts, without affecting osteoblast proliferation and viability. Drug release test demonstrated that only a fraction of the payload is released by diffusion, whereas the rest of the drug remains within the hollow core after 7 days, thus ensuring the local long-term pharmacological treatment beyond the initial fast IP release. All these data ensure an appropriate immune response to these nanospheres and the potential application of NanoMBG-IPs as local drug delivery system in osteoporotic patients.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ipriflavone; Mesoporous bioactive glasses; Nanospheres; Osteoblasts; Osteoclasts

Mesh:

Substances:

Year:  2018        PMID: 30385420     DOI: 10.1016/j.ejpb.2018.10.019

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

Review 1.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

2.  Cu-Doped Hollow Bioactive Glass Nanoparticles for Bone Infection Treatment.

Authors:  Javier Jiménez-Holguín; Sandra Sánchez-Salcedo; Mónica Cicuéndez; María Vallet-Regí; Antonio J Salinas
Journal:  Pharmaceutics       Date:  2022-04-12       Impact factor: 6.525

3.  Effects of Ipriflavone-Loaded Mesoporous Nanospheres on the Differentiation of Endothelial Progenitor Cells and Their Modulation by Macrophages.

Authors:  Laura Casarrubios; Alberto Polo-Montalvo; María Concepción Serrano; María José Feito; María Vallet-Regí; Daniel Arcos; María Teresa Portolés
Journal:  Nanomaterials (Basel)       Date:  2021-04-24       Impact factor: 5.076

4.  An Immunological Approach to the Biocompatibility of Mesoporous SiO2-CaO Nanospheres.

Authors:  María Montes-Casado; Adrian Sanvicente; Laura Casarrubios; María José Feito; José M Rojo; María Vallet-Regí; Daniel Arcos; Pilar Portolés; María Teresa Portolés
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 5.  Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-01-20       Impact factor: 6.321

Review 6.  Mesoporous Bioglasses Enriched with Bioactive Agents for Bone Repair, with a Special Highlight of María Vallet-Regí's Contribution.

Authors:  Antonio J Salinas; Pedro Esbrit
Journal:  Pharmaceutics       Date:  2022-01-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.